{"gene":"XRCC3","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":1998,"finding":"XRCC3 is a member of the RAD51 gene family and interacts directly with HsRad51, complementing the DNA damage sensitivity and chromosomal instability of irs1SF hamster cells.","method":"Sequence alignment, functional complementation, direct protein interaction assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct interaction demonstrated, functional complementation in cell line, replicated across multiple labs","pmids":["9660962"],"is_preprint":false},{"year":1998,"finding":"Xrcc3 is required for the assembly or stabilization of damage-induced Rad51 subnuclear foci in CHO cells; irs1SF cells lacking Xrcc3 fail to form Rad51 foci after ionizing radiation or cisplatin, and this defect is corrected by Xrcc3 expression.","method":"Immunofluorescence microscopy of Rad51 foci in irs1SF cells with and without Xrcc3 complementation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean complementation experiment with specific cellular phenotype, replicated in subsequent work","pmids":["9705276"],"is_preprint":false},{"year":1999,"finding":"XRCC3 promotes error-free homology-directed repair (HDR) of DNA double-strand breaks in mammalian cells; XRCC3-deficient hamster cells show a 25-fold decrease in HDR, restored to wild-type by XRCC3 expression.","method":"Fluorescence-based HDR assay in XRCC3-deficient irs1SF cells with and without XRCC3 complementation","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — quantitative functional assay, clean genetic complementation, replicated by independent labs","pmids":["10541549"],"is_preprint":false},{"year":2000,"finding":"XRCC3 is required for efficient homologous recombinational repair (HRR) of chromosomal double-strand breaks; transient complementation of irs1SF cells with XRCC3 increased HRR frequency 34- to 260-fold.","method":"DSB-induced HRR assay in irs1SF cells with transient XRCC3 expression","journal":"Mutation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — quantitative functional assay, clean loss-of-function complementation, consistent with Pierce et al. 1999","pmids":["10725659"],"is_preprint":false},{"year":2000,"finding":"Loss of XRCC3 (or XRCC2) causes highly significant increases in chromosome missegregation associated with centrosome fragmentation, indicating that unresolved DNA damage triggers this instability.","method":"Cytogenetic analysis of chromosome segregation and centrosome morphology in XRCC3-deficient cell lines","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — defined cellular phenotype (chromosome missegregation, centrosome fragmentation) in XRCC3-null cells, mechanistically linked to unresolved DNA damage","pmids":["11025669"],"is_preprint":false},{"year":2001,"finding":"Human RAD51C and XRCC3 form a stable heterodimeric complex that co-purifies from baculovirus-infected insect cells and from HeLa cell extracts; the purified RAD51C–XRCC3 complex binds single-stranded but not duplex DNA, forming protein–DNA networks visible by electron microscopy.","method":"Baculovirus co-expression, co-purification, co-immunoprecipitation from HeLa cells, electron microscopy, DNA-binding assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical reconstitution of purified complex, EM visualization, confirmed endogenous interaction in human cells","pmids":["11459987"],"is_preprint":false},{"year":2001,"finding":"The purified Xrcc3·Rad51C complex catalyzes homologous pairing in vitro; Xrcc3 is essential for the DNA-binding activity of the complex, while Rad51C is the catalytic subunit. The complex forms filamentous structures with ssDNA visible by electron microscopy.","method":"Yeast two-hybrid with brain cDNA library, baculovirus purification of Xrcc3·Rad51C, in vitro homologous pairing assay, DNA-binding assay, electron microscopy","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted biochemical activity (homologous pairing), EM structural analysis, mutagenic dissection of subunit roles","pmids":["11331762"],"is_preprint":false},{"year":2002,"finding":"XRCC3 and RAD51C interact in human cells; RAD51C, but not XRCC3, also interacts with RAD51B, RAD51D, and XRCC2, establishing two distinct paralog complexes: RAD51C–XRCC3 and RAD51B–RAD51C–RAD51D–XRCC2. Rad51 is not found in either complex. Overexpression of XRCC3 moderately elevates endogenous RAD51C, suggesting dimerization stabilizes RAD51C.","method":"Stable human cell lines expressing His-tagged XRCC3 or RAD51C; Ni2+-affinity pull-down; Western blotting","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal pull-down in human cells, defines two distinct complexes, consistent with independent biochemical work","pmids":["11842112"],"is_preprint":false},{"year":2002,"finding":"The XRCC3 variant Thr241Met is functionally active for homology-directed repair and does not confer hypersensitivity to mitomycin C, indicating that the cancer-associated polymorphism does not intrinsically disrupt HDR function.","method":"Quantitative fluorescence HDR assay; MMC sensitivity assay in XRCC3-mutant cells expressing wild-type or Thr241Met variant","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — two orthogonal functional assays (HDR frequency + MMC sensitivity) in complemented cell lines, single lab","pmids":["12037675"],"is_preprint":false},{"year":2003,"finding":"XRCC3 and Rad51 cooperatively modulate replication fork progression on damaged vertebrate chromosomes; fork slowing after cisplatin or UV is absent in irs1SF and XRCC3−/− DT40 cells, restored by addition of purified human Rad51C–XRCC3 complex to permeabilized cells, and bypassed by addition of Rad51.","method":"DNA fiber analysis; in vitro replication assay in permeabilized cells; addition of purified Rad51C–XRCC3 complex; chicken DT40 and CHO cell genetics","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with purified complex in permeabilized cells, multiple genetic backgrounds, two orthogonal systems (CHO and DT40)","pmids":["12718895"],"is_preprint":false},{"year":2004,"finding":"XRCC3 ATPase activity (Walker A motif, K113) is essential for homologous recombinational repair; ATPase mutants (K113A and K113R) fail to complement irs1SF cells. The K113A mutant still forms a stable complex with Rad51C, whereas K113R does not. Addition of ATP (but not ADP) abolishes wild-type Rad51C–XRCC3 complex formation in vitro, indicating that ATP binding/hydrolysis regulates complex dynamics.","method":"Site-directed mutagenesis of Walker A box; mammalian complementation assay; bacterial co-expression with Ni-affinity purification; Western blotting","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis combined with functional complementation and in vitro reconstitution of complex dynamics","pmids":["15037616"],"is_preprint":false},{"year":2004,"finding":"XRCC3 localizes to sites of DNA damage in human cells as distinct foci within 10 minutes of radiation treatment, independently of Rad51 (RNAi knockdown of Rad51 does not prevent Xrcc3 focus formation), consistent with a model in which Xrcc3 associates directly with DNA breaks before facilitating Rad51 nucleoprotein filament assembly.","method":"Immunofluorescence microscopy of Xrcc3 foci; RNAi-mediated Rad51 knockdown; live-cell and fixed-cell imaging","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct localization by immunofluorescence with functional context, single lab, single method for Rad51 independence","pmids":["15372620"],"is_preprint":false},{"year":2004,"finding":"Depletion of Rad51C by siRNA in human cells reduces XRCC3 protein levels, demonstrating that XRCC3 stability depends on heterodimerization with Rad51C. Rad51C depletion also reduces homologous recombination frequency and causes MMC hypersensitivity and cell-cycle-phase-specific (S and G2/M) radiosensitivity.","method":"siRNA knockdown; Western blotting; HR frequency assay; clonogenic survival; cell cycle analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal functional readouts (HR frequency, drug sensitivity, cell cycle), clean siRNA system, single lab","pmids":["15292210"],"is_preprint":false},{"year":2006,"finding":"The RAD51C–XRCC3 complex (80 kDa) co-elutes with Holliday junction resolvase activity by gel filtration and co-immunoprecipitation, indicating that the complex is associated with resolution of recombination intermediates prior to chromosome segregation.","method":"Immunoprecipitation; gel filtration; Holliday junction resolvase activity assay; mouse meiotic chromosome immunofluorescence","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — enzymatic activity (HJ resolvase) co-fractionates with complex; co-IP confirmation; two orthogonal methods in single lab","pmids":["17114795"],"is_preprint":false},{"year":2006,"finding":"XRCC3 variant D213N is defective in homologous recombination and causes increased apoptosis of cells with mitotic defects (elevated centrosome number, binucleated cells), whereas T241M is proficient in HR but also increases centrosome number/binucleation without inducing apoptosis, suggesting T241M may promote cancer by failing to eliminate mitotically aberrant cells.","method":"HR assay (MMC sensitivity complementation); centrosome counting; binucleation assay; apoptosis measurement in cells expressing XRCC3 variants","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cellular phenotype readouts for two defined variants, single lab","pmids":["16505003"],"is_preprint":false},{"year":2006,"finding":"XRCC3 deletion in DT40 cells and γH2AX mutation are synthetically lethal; both independently delay Rad51 focus formation after IR through separate arms of a branched pathway for Rad51 assembly at DSBs.","method":"Chicken DT40 double-mutant generation (XRCC3−/−/H2AX−/S139A); clonogenic survival; Rad51 focus formation; chromosomal aberration analysis; conditional transgene rescue","journal":"DNA repair","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis via synthetic lethality in vertebrate cells, conditional rescue experiment, multiple phenotypic readouts","pmids":["17123873"],"is_preprint":false},{"year":2007,"finding":"XRCC3 activity generates recombination intermediates (substrates) that give rise to elevated sister chromatid exchanges (SCE) in BLM-deficient cells; BLM with Top3α acts downstream of XRCC3 to suppress SCE formation. Disruption of XRCC3 also suppresses MMS/UV sensitivity and chromosomal aberrations of blm cells.","method":"DT40 double/triple mutant genetics; SCE assay; clonogenic survival; chromosomal aberration analysis","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis using clean double/triple mutants in DT40, multiple phenotypic readouts, places BLM downstream of XRCC3","pmids":["17923529"],"is_preprint":false},{"year":2008,"finding":"FANCG promotes formation of a protein complex containing BRCA2 (FANCD1), FANCD2, FANCG, and XRCC3 (D1-D2-G-X3); phosphorylation of FANCG serine 7 is required for co-precipitation of BRCA2, XRCC3, and FANCD2, and for direct BRCA2–FANCD2 interaction. FANCG and XRCC3 are epistatic for sensitivity to DNA crosslinking agents in DT40 cells.","method":"Co-immunoprecipitation from human and hamster cells; phospho-mutant FANCG constructs; DT40 epistasis analysis","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP defining multi-protein complex, phospho-mutant functional analysis, genetic epistasis in DT40, multiple orthogonal methods","pmids":["18212739"],"is_preprint":false},{"year":2009,"finding":"XRCC3-mediated homologous recombination and suppression of long-tract gene conversion (LTGC) during sister chromatid recombination are dependent on ATP binding and hydrolysis by XRCC3, whereas the analogous XRCC2 function does not require ATP binding/hydrolysis.","method":"Sister chromatid recombination assay in hamster cells; XRCC3 Walker motif mutants; quantification of short-tract vs. long-tract gene conversion","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis of ATPase motif with quantitative recombination assay, identifies distinct mechanistic requirement for XRCC3 vs. XRCC2","pmids":["19470754"],"is_preprint":false},{"year":2013,"finding":"ATR kinase phosphorylates XRCC3 at serine 225 (SQ motif) in an ATM-dependent signaling context; this phosphorylation requires RAD51C but not XRCC2, occurs after end resection specifically in S and G2 phases, and is required for chromatin loading of RAD51 and HR-mediated DSB repair. XRCC3 phosphorylation is also required for intra-S-phase checkpoint activation and for HR-mediated recovery of collapsed (but not stalled) replication forks; XRCC3 participates in the G2/M checkpoint independently of its phosphorylation.","method":"Phospho-specific antibodies; kinase inhibitors; phospho-site mutagenesis (S225A); siRNA; HR assay; checkpoint and replication fork recovery assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — phospho-site mutagenesis combined with multiple orthogonal functional readouts (HR, checkpoint, fork recovery), identifies writer (ATR/ATM pathway) and reader context","pmids":["23438602"],"is_preprint":false},{"year":2013,"finding":"XRCC3 cysteine residues are oxidized by ROS (UVA, various oxidants) in mammalian cells, causing increased electrophoretic mobility; oxidation is rapidly reversed by cellular reducing systems. XRCC3 localizes to both cytoplasm and nucleus; mutating all cysteines to serines does not affect localization but confers sensitivity to camptothecin (HR defect), while oxidative stress induces chromatin relocalization of both wild-type and cysteine mutant XRCC3.","method":"Non-reducing SDS-PAGE; glutathione depletion; site-directed mutagenesis (Cys→Ser); subcellular fractionation; immunofluorescence; clonogenic survival","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis and fractionation with functional survival assay, single lab, multiple readouts","pmids":["24116071"],"is_preprint":false},{"year":2018,"finding":"RAD51C/XRCC3 localizes to mitochondria and to the mitochondrial D-loop nucleoid region; this recruitment depends on Twinkle helicase. Absence of RAD51C/XRCC3 reduces POLG stability on mtDNA, decreases mtDNA synthesis, and increases mtDNA lesions under replication stress, establishing a nucleus-independent role in mitochondrial genome maintenance.","method":"Subcellular fractionation; chromatin immunoprecipitation on mtDNA; siRNA knockdown; mtDNA synthesis assay; mtDNA lesion quantification; co-immunoprecipitation with POLG and Twinkle","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (fractionation, ChIP on mtDNA, KD phenotype, co-IP), defines new subcellular role with functional consequence","pmids":["29158291"],"is_preprint":false},{"year":2023,"finding":"X-ray co-crystal structure of the RAD51C–XRCC3 (CX3) heterodimer with bound ATP analog reveals ATP-binding mode matching RAD51 recombinase, distinct CX3 interfaces, and an unappreciated polymerization motif. Cancer patient mutations mapped onto the structure define separable RAD51C functions: CX3 has discrete regions for DNA replication fork protection, restart, and reversal accomplished by separable DNA-binding and implied 5′ RAD51 filament capping activities.","method":"X-ray crystallography; CRISPR/Cas9 editing of human cells; single-molecule and single-cell assays; biophysics measurements; HDR functional analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus orthogonal functional validation (CRISPR edited cells, single-molecule assays, biophysics), multiple mechanistic readouts in one study","pmids":["37488098"],"is_preprint":false}],"current_model":"XRCC3 is a RAD51 paralog that forms a stable heterodimeric complex with RAD51C (structure now resolved by X-ray crystallography with bound ATP analog); the complex binds ssDNA, catalyzes homologous pairing, and is required for loading RAD51 onto resected DSB ends to execute homology-directed repair and suppress long-tract gene conversion. XRCC3's ATPase activity (Walker A motif K113) is essential for both HR repair and dynamic regulation of the RAD51C–XRCC3 complex. ATR/ATM-dependent phosphorylation of XRCC3 at Ser225 (requiring RAD51C) controls chromatin loading of RAD51, intra-S and G2/M checkpoints, and recovery of collapsed replication forks. XRCC3 localizes to DSBs independently of RAD51 and participates in a BRCA2–FANCD2–FANCG–XRCC3 complex (assembled via FANCG pSer7) for crosslink repair. Additionally, RAD51C/XRCC3 resides in the mitochondrial nucleoid at D-loop regulatory regions (Twinkle-dependent) where it maintains POLG stability and mtDNA integrity under replication stress."},"narrative":{"mechanistic_narrative":"XRCC3 is a RAD51-family paralog that operates as a core component of homologous recombination, executing error-free homology-directed repair of DNA double-strand breaks and maintaining chromosomal stability [PMID:9660962, PMID:10541549, PMID:11025669]. It forms a stable heterodimeric complex with RAD51C in which the two subunits are mutually stabilizing — XRCC3 elevates RAD51C levels and, reciprocally, XRCC3 protein stability depends on heterodimerization with RAD51C [PMID:11842112, PMID:15292210]. Within this complex XRCC3 is essential for single-stranded DNA binding while RAD51C provides the catalytic activity, and the reconstituted complex catalyzes homologous pairing and forms filamentous protein–DNA structures [PMID:11459987, PMID:11331762]. Functionally, XRCC3 acts upstream of RAD51 nucleoprotein filament assembly: it is required for the formation of damage-induced RAD51 subnuclear foci and localizes to DNA breaks independently of RAD51, consistent with priming RAD51 loading at resected ends [PMID:9705276, PMID:15372620]. XRCC3's ATPase activity (Walker A motif K113) is essential for recombinational repair and for suppression of long-tract gene conversion during sister chromatid recombination, with ATP binding/hydrolysis dynamically regulating RAD51C–XRCC3 complex formation [PMID:15037616, PMID:19470754]. The complex governs replication fork progression on damaged templates and co-fractionates with Holliday junction resolvase activity, generating recombination intermediates that are processed downstream by BLM–Top3α [PMID:12718895, PMID:17114795, PMID:17923529]. ATR/ATM-dependent phosphorylation of XRCC3 at Ser225, which requires RAD51C, controls RAD51 chromatin loading, intra-S checkpoint activation, and recovery of collapsed replication forks [PMID:23438602]. XRCC3 additionally participates in a BRCA2–FANCD2–FANCG–XRCC3 complex assembled via FANCG Ser7 phosphorylation for crosslink repair, and the RAD51C/XRCC3 complex carries a nucleus-independent role at the mitochondrial D-loop, where Twinkle-dependent recruitment maintains POLG stability and mtDNA integrity under replication stress [PMID:18212739, PMID:29158291]. A co-crystal structure of the RAD51C–XRCC3 heterodimer with bound ATP analog defines its ATP-binding mode and a polymerization motif, and maps separable replication fork protection, restart, and reversal functions [PMID:37488098].","teleology":[{"year":1998,"claim":"Established XRCC3 as a RAD51-family member that physically engages RAD51 and rescues the DNA-damage sensitivity of a mutant cell line, placing it in the recombinational repair machinery.","evidence":"Sequence alignment, functional complementation of irs1SF hamster cells, and direct interaction assay with HsRad51","pmids":["9660962"],"confidence":"High","gaps":["Did not define a biochemical activity for XRCC3 itself","Stoichiometry and direct binding partners beyond RAD51 unresolved"]},{"year":1998,"claim":"Showed XRCC3 acts upstream of RAD51 assembly by demonstrating it is required for damage-induced RAD51 focus formation.","evidence":"Immunofluorescence of RAD51 foci in irs1SF cells with and without XRCC3 complementation after IR or cisplatin","pmids":["9705276"],"confidence":"High","gaps":["Mechanism of how XRCC3 promotes focus assembly not defined","Direct versus indirect role unresolved at this stage"]},{"year":1999,"claim":"Quantified XRCC3's contribution as essential for error-free homology-directed repair of double-strand breaks.","evidence":"Fluorescence-based HDR assay showing 25-fold reduction in XRCC3-deficient cells, restored by complementation","pmids":["10541549","10725659"],"confidence":"High","gaps":["Step in HDR pathway requiring XRCC3 not pinpointed","Did not address mitotic or checkpoint consequences"]},{"year":2000,"claim":"Connected loss of XRCC3 to genome instability beyond repair failure, linking unresolved DNA damage to chromosome missegregation and centrosome fragmentation.","evidence":"Cytogenetic analysis of chromosome segregation and centrosome morphology in XRCC3-null cells","pmids":["11025669"],"confidence":"High","gaps":["Causal chain from repair defect to centrosome amplification not mechanistically dissected"]},{"year":2001,"claim":"Reconstituted the RAD51C–XRCC3 heterodimer biochemically and assigned subunit roles — XRCC3 confers ssDNA binding, RAD51C is catalytic — and showed the complex catalyzes homologous pairing.","evidence":"Baculovirus co-expression, co-purification, co-IP from HeLa, EM, DNA-binding and in vitro homologous pairing assays","pmids":["11459987","11331762"],"confidence":"High","gaps":["How homologous pairing activity relates to RAD51 loading in cells not resolved","Regulation of complex activity unknown"]},{"year":2002,"claim":"Defined XRCC3's place within the paralog network as part of a discrete RAD51C–XRCC3 complex distinct from the RAD51B–RAD51C–RAD51D–XRCC2 complex, with mutual subunit stabilization.","evidence":"Reciprocal His-tag pull-downs and Western blotting in stable human cell lines","pmids":["11842112"],"confidence":"High","gaps":["Functional division of labor between the two paralog complexes not established"]},{"year":2002,"claim":"Tested the cancer-associated Thr241Met polymorphism functionally and found it HDR-proficient, separating disease association from intrinsic repair disruption.","evidence":"Quantitative HDR assay and MMC sensitivity in complemented XRCC3-mutant cells","pmids":["12037675"],"confidence":"High","gaps":["Non-HDR routes by which the variant might contribute to cancer not addressed here"]},{"year":2003,"claim":"Demonstrated a replication-associated function: the RAD51C–XRCC3 complex modulates fork progression on damaged templates, with the defect rescued by purified complex and bypassed by RAD51.","evidence":"DNA fiber analysis and in vitro replication in permeabilized CHO and DT40 cells with purified complex addition","pmids":["12718895"],"confidence":"High","gaps":["Molecular event at the fork requiring XRCC3 not defined","Relationship to RAD51 loading at forks unresolved"]},{"year":2004,"claim":"Identified XRCC3 ATPase activity (Walker A K113) as essential for repair and as a regulator of complex dynamics, with ATP binding modulating RAD51C–XRCC3 association.","evidence":"Walker A mutagenesis (K113A/K113R), mammalian complementation, bacterial co-expression and purification","pmids":["15037616"],"confidence":"High","gaps":["How ATP-driven dynamics couple to RAD51 loading in vivo not shown","Catalytic versus structural role of hydrolysis not fully separated"]},{"year":2004,"claim":"Showed XRCC3 localizes to breaks within minutes independently of RAD51, supporting a model where it associates with DNA breaks before facilitating RAD51 filament assembly; and confirmed XRCC3 stability depends on RAD51C.","evidence":"Immunofluorescence of XRCC3 foci with RAD51 RNAi; siRNA depletion of RAD51C with Western, HR, and survival readouts","pmids":["15372620","15292210"],"confidence":"Medium","gaps":["RAD51-independent recruitment shown by single method (idx 11)","Recruitment receptor at breaks not identified"]},{"year":2006,"claim":"Linked the complex to resolution of recombination intermediates by showing co-elution with Holliday junction resolvase activity.","evidence":"IP, gel filtration, HJ resolvase assay, and meiotic chromosome immunofluorescence","pmids":["17114795"],"confidence":"High","gaps":["Whether XRCC3/RAD51C is the resolvase or an associated factor not resolved","Identity of catalytic resolvase activity not assigned"]},{"year":2006,"claim":"Dissected two XRCC3 variants to show HR proficiency and mitotic surveillance are separable, with T241M increasing centrosome/binucleation defects without triggering apoptosis.","evidence":"HR complementation, centrosome counting, binucleation and apoptosis assays for D213N and T241M variants","pmids":["16505003"],"confidence":"Medium","gaps":["Single-lab variant phenotyping","Mechanism linking XRCC3 to apoptotic elimination of aberrant cells not defined"]},{"year":2006,"claim":"Positioned XRCC3 in a branched RAD51-loading pathway by showing synthetic lethality with γH2AX, with each acting through a separate arm.","evidence":"DT40 double mutants (XRCC3−/−/H2AX−), clonogenic survival, RAD51 focus and aberration analysis with conditional rescue","pmids":["17123873"],"confidence":"High","gaps":["Molecular distinction between the two RAD51-loading arms not fully defined"]},{"year":2007,"claim":"Placed XRCC3 upstream of BLM–Top3α by showing XRCC3 generates recombination intermediates that BLM resolves to suppress sister chromatid exchange.","evidence":"DT40 double/triple mutant epistasis, SCE assay, survival and chromosomal aberration analysis","pmids":["17923529"],"confidence":"High","gaps":["Nature of the XRCC3-generated intermediate not biochemically defined"]},{"year":2008,"claim":"Embedded XRCC3 in the Fanconi crosslink-repair axis via a phospho-dependent BRCA2–FANCD2–FANCG–XRCC3 complex.","evidence":"Co-IP from human and hamster cells, FANCG pSer7 phospho-mutant constructs, DT40 epistasis with crosslinkers","pmids":["18212739"],"confidence":"High","gaps":["Direct XRCC3 contact within the complex not mapped","How this complex couples to HR machinery not defined"]},{"year":2013,"claim":"Identified XRCC3 Ser225 as an ATR/ATM-pathway phosphosite (RAD51C-dependent) controlling RAD51 chromatin loading, the intra-S checkpoint, and collapsed-fork recovery, separating these from a phosphorylation-independent G2/M checkpoint role.","evidence":"Phospho-specific antibodies, kinase inhibitors, S225A mutagenesis, siRNA, HR, checkpoint and fork recovery assays","pmids":["23438602"],"confidence":"High","gaps":["Direct reader of phospho-Ser225 not identified","Structural consequence of phosphorylation not defined"]},{"year":2013,"claim":"Revealed redox regulation: XRCC3 cysteines are reversibly oxidized by ROS and required for HR/camptothecin resistance, with oxidative stress driving chromatin relocalization.","evidence":"Non-reducing SDS-PAGE, glutathione depletion, Cys→Ser mutagenesis, fractionation, immunofluorescence, clonogenic survival","pmids":["24116071"],"confidence":"Medium","gaps":["Single-lab study","Physiological context where cysteine oxidation regulates XRCC3 not established"]},{"year":2018,"claim":"Uncovered a nucleus-independent mitochondrial role: Twinkle-dependent recruitment of RAD51C/XRCC3 to the mtDNA D-loop maintains POLG stability and mtDNA integrity under replication stress.","evidence":"Subcellular fractionation, ChIP on mtDNA, siRNA, mtDNA synthesis and lesion assays, co-IP with POLG and Twinkle","pmids":["29158291"],"confidence":"High","gaps":["Whether mitochondrial function uses HR-like activity not resolved","Direct XRCC3 contribution versus RAD51C not separated"]},{"year":2023,"claim":"Provided the structural basis for XRCC3 function — a RAD51C–XRCC3 co-crystal with bound ATP analog revealing the ATP-binding mode, complex interfaces, and a polymerization motif, with mapping of separable fork protection/restart/reversal functions.","evidence":"X-ray crystallography, CRISPR editing, single-molecule and single-cell assays, biophysics, HDR analysis","pmids":["37488098"],"confidence":"High","gaps":["Structure of the complex engaged with DNA or RAD51 filament not resolved","Implied 5′ filament capping activity not directly visualized"]},{"year":null,"claim":"How XRCC3's distinct activities — nuclear HR, replication fork protection, crosslink repair, and mitochondrial genome maintenance — are coordinated, and what directly reads its regulatory modifications, remains open.","evidence":"","pmids":[],"confidence":"High","gaps":["No reader of phospho-Ser225 identified","Structural picture of DNA/RAD51-engaged complex lacking","Coupling of mitochondrial and nuclear roles undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[10,18,22]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5,6]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[10,18]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,1,11]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,11,20]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[11,19]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[20]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[21]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[0,2,3,19]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[9,19,21]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[4,13,19]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[21]}],"complexes":["RAD51C–XRCC3 (CX3) heterodimer","BRCA2–FANCD2–FANCG–XRCC3","mitochondrial D-loop nucleoid complex (with POLG/Twinkle)"],"partners":["RAD51C","RAD51","BRCA2","FANCD2","FANCG","POLG","TWNK"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O43542","full_name":"DNA repair protein XRCC3","aliases":["X-ray repair cross-complementing protein 3"],"length_aa":346,"mass_kda":37.9,"function":"Involved in the homologous recombination repair (HRR) pathway of double-stranded DNA, thought to repair chromosomal fragmentation, translocations and deletions. Part of the RAD51 paralog protein complex CX3 which acts in the BRCA1-BRCA2-dependent HR pathway. Upon DNA damage, CX3 acts downstream of RAD51 recruitment; the complex binds predominantly to the intersection of the four duplex arms of the Holliday junction (HJ) and to junctions of replication forks. Involved in HJ resolution and thus in processing HR intermediates late in the DNA repair process; the function may be linked to the CX3 complex and seems to involve GEN1 during mitotic cell cycle progression. Part of a PALB2-scaffolded HR complex containing BRCA2 and RAD51C and which is thought to play a role in DNA repair by HR. Plays a role in regulating mitochondrial DNA copy number under conditions of oxidative stress in the presence of RAD51 and RAD51C","subcellular_location":"Nucleus; Cytoplasm; Cytoplasm, perinuclear region; Mitochondrion","url":"https://www.uniprot.org/uniprotkb/O43542/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/XRCC3","classification":"Common Essential","n_dependent_lines":800,"n_total_lines":1208,"dependency_fraction":0.6622516556291391},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/XRCC3","total_profiled":1310},"omim":[{"mim_id":"613984","title":"FANCD2 GENE; FANCD2","url":"https://www.omim.org/entry/613984"},{"mim_id":"613972","title":"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6; CMM6","url":"https://www.omim.org/entry/613972"},{"mim_id":"602956","title":"FANCG GENE; FANCG","url":"https://www.omim.org/entry/602956"},{"mim_id":"602954","title":"RAD51 PARALOG D; RAD51D","url":"https://www.omim.org/entry/602954"},{"mim_id":"602948","title":"RAD51 PARALOG B; RAD51B","url":"https://www.omim.org/entry/602948"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/XRCC3"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"O43542","domains":[{"cath_id":"3.40.50.300","chopping":"78-263_277-346","consensus_level":"high","plddt":91.1233,"start":78,"end":346},{"cath_id":"1.10.150","chopping":"4-58","consensus_level":"high","plddt":90.7829,"start":4,"end":58}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43542","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43542-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43542-F1-predicted_aligned_error_v6.png","plddt_mean":87.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=XRCC3","jax_strain_url":"https://www.jax.org/strain/search?query=XRCC3"},"sequence":{"accession":"O43542","fasta_url":"https://rest.uniprot.org/uniprotkb/O43542.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43542/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43542"}},"corpus_meta":[{"pmid":"10541549","id":"PMC_10541549","title":"XRCC3 promotes homology-directed repair of DNA damage in mammalian cells.","date":"1999","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/10541549","citation_count":1174,"is_preprint":false},{"pmid":"9660962","id":"PMC_9660962","title":"XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages.","date":"1998","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/9660962","citation_count":456,"is_preprint":false},{"pmid":"11532866","id":"PMC_11532866","title":"XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects.","date":"2001","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/11532866","citation_count":404,"is_preprint":false},{"pmid":"9705276","id":"PMC_9705276","title":"Xrcc3 is required for assembly of Rad51 complexes in vivo.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9705276","citation_count":234,"is_preprint":false},{"pmid":"11059748","id":"PMC_11059748","title":"A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer.","date":"2000","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11059748","citation_count":227,"is_preprint":false},{"pmid":"11025669","id":"PMC_11025669","title":"Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation.","date":"2000","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11025669","citation_count":196,"is_preprint":false},{"pmid":"16707649","id":"PMC_16707649","title":"XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review.","date":"2006","source":"American journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/16707649","citation_count":166,"is_preprint":false},{"pmid":"12565173","id":"PMC_12565173","title":"Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer.","date":"2003","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/12565173","citation_count":158,"is_preprint":false},{"pmid":"10725659","id":"PMC_10725659","title":"XRCC3 is required for efficient repair of chromosome breaks by homologous recombination.","date":"2000","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/10725659","citation_count":149,"is_preprint":false},{"pmid":"12718895","id":"PMC_12718895","title":"XRCC3 and Rad51 modulate replication fork progression on damaged vertebrate chromosomes.","date":"2003","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/12718895","citation_count":139,"is_preprint":false},{"pmid":"11459987","id":"PMC_11459987","title":"Complex formation by the human RAD51C and XRCC3 recombination repair proteins.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11459987","citation_count":111,"is_preprint":false},{"pmid":"11331762","id":"PMC_11331762","title":"Homologous-pairing activity of the human DNA-repair proteins Xrcc3.Rad51C.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11331762","citation_count":108,"is_preprint":false},{"pmid":"10422536","id":"PMC_10422536","title":"The XRCC2 and XRCC3 repair genes are required for chromosome stability in mammalian cells.","date":"1999","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/10422536","citation_count":107,"is_preprint":false},{"pmid":"15491645","id":"PMC_15491645","title":"Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionising radiations?","date":"2004","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/15491645","citation_count":101,"is_preprint":false},{"pmid":"11842112","id":"PMC_11842112","title":"Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human cells.","date":"2002","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11842112","citation_count":97,"is_preprint":false},{"pmid":"12037675","id":"PMC_12037675","title":"Variant XRCC3 implicated in cancer is functional in homology-directed repair of double-strand breaks.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12037675","citation_count":96,"is_preprint":false},{"pmid":"17114795","id":"PMC_17114795","title":"Role of RAD51C and XRCC3 in genetic recombination and DNA repair.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17114795","citation_count":92,"is_preprint":false},{"pmid":"12223443","id":"PMC_12223443","title":"DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk.","date":"2002","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12223443","citation_count":85,"is_preprint":false},{"pmid":"15386379","id":"PMC_15386379","title":"DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract.","date":"2004","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15386379","citation_count":79,"is_preprint":false},{"pmid":"16791138","id":"PMC_16791138","title":"DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies.","date":"2006","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/16791138","citation_count":77,"is_preprint":false},{"pmid":"18330515","id":"PMC_18330515","title":"XRCC1 and XRCC3 variants and risk of glioma and meningioma.","date":"2008","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/18330515","citation_count":77,"is_preprint":false},{"pmid":"19031937","id":"PMC_19031937","title":"Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.","date":"2008","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19031937","citation_count":77,"is_preprint":false},{"pmid":"15066923","id":"PMC_15066923","title":"Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.","date":"2004","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/15066923","citation_count":75,"is_preprint":false},{"pmid":"18212739","id":"PMC_18212739","title":"FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.","date":"2008","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/18212739","citation_count":69,"is_preprint":false},{"pmid":"17116943","id":"PMC_17116943","title":"Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer.","date":"2006","source":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17116943","citation_count":67,"is_preprint":false},{"pmid":"16234265","id":"PMC_16234265","title":"Risk assessment of welders using analysis of eight metals by ICP-MS in blood and urine and DNA damage evaluation by the comet and micronucleus assays; influence of XRCC1 and XRCC3 polymorphisms.","date":"2005","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/16234265","citation_count":62,"is_preprint":false},{"pmid":"17986315","id":"PMC_17986315","title":"XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer.","date":"2007","source":"The American journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/17986315","citation_count":60,"is_preprint":false},{"pmid":"23438602","id":"PMC_23438602","title":"ATM- and ATR-mediated phosphorylation of XRCC3 regulates DNA double-strand break-induced checkpoint activation and repair.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23438602","citation_count":58,"is_preprint":false},{"pmid":"17971348","id":"PMC_17971348","title":"hOGG1(326), XRCC1(399) and XRCC3(241) polymorphisms influence micronucleus frequencies in human lymphocytes in vivo.","date":"2007","source":"Mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/17971348","citation_count":58,"is_preprint":false},{"pmid":"19414392","id":"PMC_19414392","title":"Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1).","date":"2009","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19414392","citation_count":56,"is_preprint":false},{"pmid":"19815090","id":"PMC_19815090","title":"Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?","date":"2009","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/19815090","citation_count":52,"is_preprint":false},{"pmid":"17901044","id":"PMC_17901044","title":"Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17901044","citation_count":52,"is_preprint":false},{"pmid":"15292210","id":"PMC_15292210","title":"Human Rad51C deficiency destabilizes XRCC3, impairs recombination, and radiosensitizes S/G2-phase cells.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15292210","citation_count":51,"is_preprint":false},{"pmid":"16492913","id":"PMC_16492913","title":"Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma.","date":"2006","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16492913","citation_count":50,"is_preprint":false},{"pmid":"19470754","id":"PMC_19470754","title":"XRCC2 and XRCC3 regulate the balance between short- and long-tract gene conversions between sister chromatids.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19470754","citation_count":50,"is_preprint":false},{"pmid":"19393248","id":"PMC_19393248","title":"Genetic polymorphisms in XRCC1, OGG1, APE1 and XRCC3 DNA repair genes, ionizing radiation exposure and chromosomal DNA damage in interventional cardiologists.","date":"2009","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/19393248","citation_count":49,"is_preprint":false},{"pmid":"20229274","id":"PMC_20229274","title":"Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case-control study in an Indian population.","date":"2010","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/20229274","citation_count":48,"is_preprint":false},{"pmid":"12115490","id":"PMC_12115490","title":"A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis.","date":"2002","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12115490","citation_count":47,"is_preprint":false},{"pmid":"22524842","id":"PMC_22524842","title":"Genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 and risk of colorectal cancer in Chinese population.","date":"2012","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/22524842","citation_count":47,"is_preprint":false},{"pmid":"18630471","id":"PMC_18630471","title":"DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort.","date":"2008","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18630471","citation_count":47,"is_preprint":false},{"pmid":"15372620","id":"PMC_15372620","title":"Xrcc3 is recruited to DNA double strand breaks early and independent of Rad51.","date":"2004","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15372620","citation_count":46,"is_preprint":false},{"pmid":"16963196","id":"PMC_16963196","title":"No association between XRCC1 and XRCC3 gene polymorphisms and breast cancer risk: Iowa Women's Health Study.","date":"2006","source":"Cancer detection and prevention","url":"https://pubmed.ncbi.nlm.nih.gov/16963196","citation_count":45,"is_preprint":false},{"pmid":"15019159","id":"PMC_15019159","title":"Polymorphisms of DNA repair gene XRCC3 Thr241Met and risk of gastric cancer in a Chinese population.","date":"2004","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/15019159","citation_count":44,"is_preprint":false},{"pmid":"20804747","id":"PMC_20804747","title":"Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population.","date":"2010","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20804747","citation_count":43,"is_preprint":false},{"pmid":"29158291","id":"PMC_29158291","title":"RAD51C/XRCC3 Facilitates Mitochondrial DNA Replication and Maintains Integrity of the Mitochondrial Genome.","date":"2018","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29158291","citation_count":42,"is_preprint":false},{"pmid":"23289442","id":"PMC_23289442","title":"XRCC3 Thr241Met gene polymorphisms and lung cancer risk: a meta-analysis.","date":"2013","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/23289442","citation_count":42,"is_preprint":false},{"pmid":"17164360","id":"PMC_17164360","title":"XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk.","date":"2006","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17164360","citation_count":42,"is_preprint":false},{"pmid":"23409158","id":"PMC_23409158","title":"The relationship between XRCC1 and XRCC3 gene polymorphisms and lung cancer risk in northeastern Chinese.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23409158","citation_count":41,"is_preprint":false},{"pmid":"9930366","id":"PMC_9930366","title":"Increased expression of human DNA repair genes, XRCC1, XRCC3 and RAD51, in radioresistant human KB carcinoma cell line N10.","date":"1998","source":"Oral oncology","url":"https://pubmed.ncbi.nlm.nih.gov/9930366","citation_count":41,"is_preprint":false},{"pmid":"19789975","id":"PMC_19789975","title":"XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis.","date":"2009","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/19789975","citation_count":39,"is_preprint":false},{"pmid":"17123873","id":"PMC_17123873","title":"Collaborative roles of gammaH2AX and the Rad51 paralog Xrcc3 in homologous recombinational repair.","date":"2006","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/17123873","citation_count":38,"is_preprint":false},{"pmid":"16271954","id":"PMC_16271954","title":"The association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population.","date":"2005","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/16271954","citation_count":38,"is_preprint":false},{"pmid":"15354414","id":"PMC_15354414","title":"An association of polymorphism of DNA repair genes XRCC1 and XRCC3 with colorectal cancer.","date":"2004","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/15354414","citation_count":37,"is_preprint":false},{"pmid":"18504145","id":"PMC_18504145","title":"The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China.","date":"2008","source":"Annals of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/18504145","citation_count":37,"is_preprint":false},{"pmid":"15767338","id":"PMC_15767338","title":"XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk.","date":"2005","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/15767338","citation_count":35,"is_preprint":false},{"pmid":"21617942","id":"PMC_21617942","title":"Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer.","date":"2011","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21617942","citation_count":34,"is_preprint":false},{"pmid":"22613844","id":"PMC_22613844","title":"Genetic variability of Xrcc3 and Rad51 modulates the risk of head and neck cancer.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/22613844","citation_count":33,"is_preprint":false},{"pmid":"37488098","id":"PMC_37488098","title":"RAD51C-XRCC3 structure and cancer patient mutations define DNA replication roles.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37488098","citation_count":32,"is_preprint":false},{"pmid":"16505003","id":"PMC_16505003","title":"Mitotic defects in XRCC3 variants T241M and D213N and their relation to cancer susceptibility.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16505003","citation_count":32,"is_preprint":false},{"pmid":"29574277","id":"PMC_29574277","title":"XRCC3 contributes to temozolomide resistance of glioblastoma cells by promoting DNA double-strand break repair.","date":"2018","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/29574277","citation_count":31,"is_preprint":false},{"pmid":"22775506","id":"PMC_22775506","title":"Allelic variants of XRCC1 and XRCC3 repair genes and susceptibility of oral cancer in Brazilian patients.","date":"2012","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22775506","citation_count":31,"is_preprint":false},{"pmid":"25831063","id":"PMC_25831063","title":"A systematic gene-gene and gene-environment interaction analysis of DNA repair genes XRCC1, XRCC2, XRCC3, XRCC4, and oral cancer risk.","date":"2015","source":"Omics : a journal of integrative biology","url":"https://pubmed.ncbi.nlm.nih.gov/25831063","citation_count":30,"is_preprint":false},{"pmid":"22161248","id":"PMC_22161248","title":"Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case-control studies.","date":"2011","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/22161248","citation_count":29,"is_preprint":false},{"pmid":"21725251","id":"PMC_21725251","title":"RAD51 and XRCC3 gene polymorphisms and the risk of developing acute myeloid leukemia.","date":"2011","source":"Journal of investigative medicine : the official publication of the American Federation for Clinical Research","url":"https://pubmed.ncbi.nlm.nih.gov/21725251","citation_count":29,"is_preprint":false},{"pmid":"20590474","id":"PMC_20590474","title":"Polymorphic variants of DNA repair gene XRCC3 and XRCC7 and risk of prostate cancer: a study from North Indian population.","date":"2010","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20590474","citation_count":29,"is_preprint":false},{"pmid":"26938431","id":"PMC_26938431","title":"Association Studies Between XRCC1, XRCC2, XRCC3 Polymorphisms and Differentiated Thyroid Carcinoma.","date":"2016","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26938431","citation_count":28,"is_preprint":false},{"pmid":"27683114","id":"PMC_27683114","title":"Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27683114","citation_count":28,"is_preprint":false},{"pmid":"23977219","id":"PMC_23977219","title":"XRCC3 and RAD51 expression are associated with clinical factors in breast cancer.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23977219","citation_count":27,"is_preprint":false},{"pmid":"19096231","id":"PMC_19096231","title":"Susceptibility of XRCC3, XPD, and XPG genetic variants to cervical carcinoma.","date":"2008","source":"Pathobiology : journal of immunopathology, molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19096231","citation_count":27,"is_preprint":false},{"pmid":"21725594","id":"PMC_21725594","title":"Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity.","date":"2011","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/21725594","citation_count":27,"is_preprint":false},{"pmid":"24454720","id":"PMC_24454720","title":"XRCC3 C18067T polymorphism contributes a decreased risk to both basal cell carcinoma and squamous cell carcinoma: evidence from a meta-analysis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24454720","citation_count":26,"is_preprint":false},{"pmid":"26034131","id":"PMC_26034131","title":"XRCC3 is essential for proper double-strand break repair and homologous recombination in rice meiosis.","date":"2015","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/26034131","citation_count":26,"is_preprint":false},{"pmid":"23959014","id":"PMC_23959014","title":"DNA Repair Genes XRCC1, XRCC3, XPD, and OGG1 Polymorphisms among the Central Region Population of Saudi Arabia.","date":"2013","source":"Biological research","url":"https://pubmed.ncbi.nlm.nih.gov/23959014","citation_count":25,"is_preprint":false},{"pmid":"26001739","id":"PMC_26001739","title":"DNA repair genes XPC, XPD, XRCC1, and XRCC3 are associated with risk and survival of squamous cell carcinoma of the head and neck.","date":"2015","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/26001739","citation_count":25,"is_preprint":false},{"pmid":"25340946","id":"PMC_25340946","title":"Association of DNA repair genes XRCC1 (Arg399Gln), (Arg194Trp) and XRCC3 (Thr241Met) polymorphisms with the risk of breast cancer: a case-control study in Egypt.","date":"2014","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/25340946","citation_count":25,"is_preprint":false},{"pmid":"21790234","id":"PMC_21790234","title":"Genetic risk of DNA repair gene polymorphisms (XRCC1 and XRCC3) for high risk human papillomavirus negative cervical cancer in Northeast Thailand.","date":"2011","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/21790234","citation_count":25,"is_preprint":false},{"pmid":"23539294","id":"PMC_23539294","title":"XRCC2 R188H (rs3218536), XRCC3 T241M (rs861539) and R243H (rs77381814) single nucleotide polymorphisms in cervical cancer risk.","date":"2013","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/23539294","citation_count":24,"is_preprint":false},{"pmid":"14534887","id":"PMC_14534887","title":"XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations.","date":"2003","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/14534887","citation_count":24,"is_preprint":false},{"pmid":"26045834","id":"PMC_26045834","title":"Association between XRCC1 and XRCC3 gene polymorphisms and risk of thyroid cancer.","date":"2015","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26045834","citation_count":23,"is_preprint":false},{"pmid":"22370935","id":"PMC_22370935","title":"Variation in DNA repair gene XRCC3 affects susceptibility to astrocytomas and glioblastomas.","date":"2012","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/22370935","citation_count":23,"is_preprint":false},{"pmid":"15037616","id":"PMC_15037616","title":"XRCC3 ATPase activity is required for normal XRCC3-Rad51C complex dynamics and homologous recombination.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15037616","citation_count":23,"is_preprint":false},{"pmid":"24922659","id":"PMC_24922659","title":"Contribution of DNA double-strand break repair gene XRCC3 genotypes to oral cancer susceptibility in Taiwan.","date":"2014","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24922659","citation_count":23,"is_preprint":false},{"pmid":"25918678","id":"PMC_25918678","title":"RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families.","date":"2015","source":"SpringerPlus","url":"https://pubmed.ncbi.nlm.nih.gov/25918678","citation_count":22,"is_preprint":false},{"pmid":"26383967","id":"PMC_26383967","title":"XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma.","date":"2015","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/26383967","citation_count":22,"is_preprint":false},{"pmid":"28345844","id":"PMC_28345844","title":"Association between the DNA Repair Gene XRCC3 rs861539 Polymorphism and Risk of Osteosarcoma: a Systematic Review and Meta-Analysis.","date":"2017","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/28345844","citation_count":22,"is_preprint":false},{"pmid":"24116071","id":"PMC_24116071","title":"Oxidative stress in mammalian cells impinges on the cysteines redox state of human XRCC3 protein and on its cellular localization.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24116071","citation_count":22,"is_preprint":false},{"pmid":"22374424","id":"PMC_22374424","title":"Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients.","date":"2012","source":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico","url":"https://pubmed.ncbi.nlm.nih.gov/22374424","citation_count":22,"is_preprint":false},{"pmid":"26801223","id":"PMC_26801223","title":"Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women.","date":"2016","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26801223","citation_count":22,"is_preprint":false},{"pmid":"25006581","id":"PMC_25006581","title":"Analyzing association of the XRCC3 gene polymorphism with ovarian cancer risk.","date":"2014","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/25006581","citation_count":21,"is_preprint":false},{"pmid":"26091483","id":"PMC_26091483","title":"Association between Single Nucleotide Polymorphisms in XRCC3 and Radiation-Induced Adverse Effects on Normal Tissue: A Meta-Analysis.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26091483","citation_count":21,"is_preprint":false},{"pmid":"26543082","id":"PMC_26543082","title":"Contribution of DNA Double-strand Break Repair Gene XRCC3 Genotypes to Triple-negative Breast Cancer Risk.","date":"2015","source":"Cancer genomics & proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/26543082","citation_count":20,"is_preprint":false},{"pmid":"27819744","id":"PMC_27819744","title":"Correlation between gene polymorphisms of CYP1A1, GSTP1, ERCC2, XRCC1, and XRCC3 and susceptibility to lung cancer.","date":"2016","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/27819744","citation_count":20,"is_preprint":false},{"pmid":"22299591","id":"PMC_22299591","title":"DNA repair gene XRCC3 T241M polymorphism and bladder cancer risk in a Chinese population.","date":"2012","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/22299591","citation_count":20,"is_preprint":false},{"pmid":"17923529","id":"PMC_17923529","title":"Functional interactions between BLM and XRCC3 in the cell.","date":"2007","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17923529","citation_count":19,"is_preprint":false},{"pmid":"24197974","id":"PMC_24197974","title":"Quantitative assessment of the associations between DNA repair gene XRCC3 Thr241Met polymorphism and gastric cancer.","date":"2013","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24197974","citation_count":19,"is_preprint":false},{"pmid":"23271134","id":"PMC_23271134","title":"Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies.","date":"2012","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23271134","citation_count":19,"is_preprint":false},{"pmid":"28490032","id":"PMC_28490032","title":"Haplotype Based Analysis of XRCC3 Gene Polymorphisms in Thyroid Cancer.","date":"2017","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28490032","citation_count":19,"is_preprint":false},{"pmid":"25556492","id":"PMC_25556492","title":"Association of RAD 51 135 G/C, 172 G/T and XRCC3 Thr241Met gene polymorphisms with increased risk of head and neck cancer.","date":"2014","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/25556492","citation_count":19,"is_preprint":false},{"pmid":"20549576","id":"PMC_20549576","title":"Relationship between XRCC3 T241M polymorphism and gastric cancer risk: a meta-analysis.","date":"2010","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20549576","citation_count":18,"is_preprint":false},{"pmid":"26881229","id":"PMC_26881229","title":"Polymorphisms in DNA Repair Gene XRCC3 and Susceptibility to Breast Cancer in Saudi Females.","date":"2016","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/26881229","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53683,"output_tokens":5817,"usd":0.124152,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14408,"output_tokens":5869,"usd":0.109382,"stage2_stop_reason":"end_turn"},"total_usd":0.233534,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"XRCC3 is a member of the RAD51 gene family and interacts directly with HsRad51, complementing the DNA damage sensitivity and chromosomal instability of irs1SF hamster cells.\",\n      \"method\": \"Sequence alignment, functional complementation, direct protein interaction assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct interaction demonstrated, functional complementation in cell line, replicated across multiple labs\",\n      \"pmids\": [\"9660962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Xrcc3 is required for the assembly or stabilization of damage-induced Rad51 subnuclear foci in CHO cells; irs1SF cells lacking Xrcc3 fail to form Rad51 foci after ionizing radiation or cisplatin, and this defect is corrected by Xrcc3 expression.\",\n      \"method\": \"Immunofluorescence microscopy of Rad51 foci in irs1SF cells with and without Xrcc3 complementation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean complementation experiment with specific cellular phenotype, replicated in subsequent work\",\n      \"pmids\": [\"9705276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"XRCC3 promotes error-free homology-directed repair (HDR) of DNA double-strand breaks in mammalian cells; XRCC3-deficient hamster cells show a 25-fold decrease in HDR, restored to wild-type by XRCC3 expression.\",\n      \"method\": \"Fluorescence-based HDR assay in XRCC3-deficient irs1SF cells with and without XRCC3 complementation\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — quantitative functional assay, clean genetic complementation, replicated by independent labs\",\n      \"pmids\": [\"10541549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"XRCC3 is required for efficient homologous recombinational repair (HRR) of chromosomal double-strand breaks; transient complementation of irs1SF cells with XRCC3 increased HRR frequency 34- to 260-fold.\",\n      \"method\": \"DSB-induced HRR assay in irs1SF cells with transient XRCC3 expression\",\n      \"journal\": \"Mutation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — quantitative functional assay, clean loss-of-function complementation, consistent with Pierce et al. 1999\",\n      \"pmids\": [\"10725659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Loss of XRCC3 (or XRCC2) causes highly significant increases in chromosome missegregation associated with centrosome fragmentation, indicating that unresolved DNA damage triggers this instability.\",\n      \"method\": \"Cytogenetic analysis of chromosome segregation and centrosome morphology in XRCC3-deficient cell lines\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — defined cellular phenotype (chromosome missegregation, centrosome fragmentation) in XRCC3-null cells, mechanistically linked to unresolved DNA damage\",\n      \"pmids\": [\"11025669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Human RAD51C and XRCC3 form a stable heterodimeric complex that co-purifies from baculovirus-infected insect cells and from HeLa cell extracts; the purified RAD51C–XRCC3 complex binds single-stranded but not duplex DNA, forming protein–DNA networks visible by electron microscopy.\",\n      \"method\": \"Baculovirus co-expression, co-purification, co-immunoprecipitation from HeLa cells, electron microscopy, DNA-binding assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical reconstitution of purified complex, EM visualization, confirmed endogenous interaction in human cells\",\n      \"pmids\": [\"11459987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The purified Xrcc3·Rad51C complex catalyzes homologous pairing in vitro; Xrcc3 is essential for the DNA-binding activity of the complex, while Rad51C is the catalytic subunit. The complex forms filamentous structures with ssDNA visible by electron microscopy.\",\n      \"method\": \"Yeast two-hybrid with brain cDNA library, baculovirus purification of Xrcc3·Rad51C, in vitro homologous pairing assay, DNA-binding assay, electron microscopy\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted biochemical activity (homologous pairing), EM structural analysis, mutagenic dissection of subunit roles\",\n      \"pmids\": [\"11331762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"XRCC3 and RAD51C interact in human cells; RAD51C, but not XRCC3, also interacts with RAD51B, RAD51D, and XRCC2, establishing two distinct paralog complexes: RAD51C–XRCC3 and RAD51B–RAD51C–RAD51D–XRCC2. Rad51 is not found in either complex. Overexpression of XRCC3 moderately elevates endogenous RAD51C, suggesting dimerization stabilizes RAD51C.\",\n      \"method\": \"Stable human cell lines expressing His-tagged XRCC3 or RAD51C; Ni2+-affinity pull-down; Western blotting\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal pull-down in human cells, defines two distinct complexes, consistent with independent biochemical work\",\n      \"pmids\": [\"11842112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The XRCC3 variant Thr241Met is functionally active for homology-directed repair and does not confer hypersensitivity to mitomycin C, indicating that the cancer-associated polymorphism does not intrinsically disrupt HDR function.\",\n      \"method\": \"Quantitative fluorescence HDR assay; MMC sensitivity assay in XRCC3-mutant cells expressing wild-type or Thr241Met variant\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal functional assays (HDR frequency + MMC sensitivity) in complemented cell lines, single lab\",\n      \"pmids\": [\"12037675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"XRCC3 and Rad51 cooperatively modulate replication fork progression on damaged vertebrate chromosomes; fork slowing after cisplatin or UV is absent in irs1SF and XRCC3−/− DT40 cells, restored by addition of purified human Rad51C–XRCC3 complex to permeabilized cells, and bypassed by addition of Rad51.\",\n      \"method\": \"DNA fiber analysis; in vitro replication assay in permeabilized cells; addition of purified Rad51C–XRCC3 complex; chicken DT40 and CHO cell genetics\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with purified complex in permeabilized cells, multiple genetic backgrounds, two orthogonal systems (CHO and DT40)\",\n      \"pmids\": [\"12718895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"XRCC3 ATPase activity (Walker A motif, K113) is essential for homologous recombinational repair; ATPase mutants (K113A and K113R) fail to complement irs1SF cells. The K113A mutant still forms a stable complex with Rad51C, whereas K113R does not. Addition of ATP (but not ADP) abolishes wild-type Rad51C–XRCC3 complex formation in vitro, indicating that ATP binding/hydrolysis regulates complex dynamics.\",\n      \"method\": \"Site-directed mutagenesis of Walker A box; mammalian complementation assay; bacterial co-expression with Ni-affinity purification; Western blotting\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis combined with functional complementation and in vitro reconstitution of complex dynamics\",\n      \"pmids\": [\"15037616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"XRCC3 localizes to sites of DNA damage in human cells as distinct foci within 10 minutes of radiation treatment, independently of Rad51 (RNAi knockdown of Rad51 does not prevent Xrcc3 focus formation), consistent with a model in which Xrcc3 associates directly with DNA breaks before facilitating Rad51 nucleoprotein filament assembly.\",\n      \"method\": \"Immunofluorescence microscopy of Xrcc3 foci; RNAi-mediated Rad51 knockdown; live-cell and fixed-cell imaging\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct localization by immunofluorescence with functional context, single lab, single method for Rad51 independence\",\n      \"pmids\": [\"15372620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Depletion of Rad51C by siRNA in human cells reduces XRCC3 protein levels, demonstrating that XRCC3 stability depends on heterodimerization with Rad51C. Rad51C depletion also reduces homologous recombination frequency and causes MMC hypersensitivity and cell-cycle-phase-specific (S and G2/M) radiosensitivity.\",\n      \"method\": \"siRNA knockdown; Western blotting; HR frequency assay; clonogenic survival; cell cycle analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal functional readouts (HR frequency, drug sensitivity, cell cycle), clean siRNA system, single lab\",\n      \"pmids\": [\"15292210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The RAD51C–XRCC3 complex (80 kDa) co-elutes with Holliday junction resolvase activity by gel filtration and co-immunoprecipitation, indicating that the complex is associated with resolution of recombination intermediates prior to chromosome segregation.\",\n      \"method\": \"Immunoprecipitation; gel filtration; Holliday junction resolvase activity assay; mouse meiotic chromosome immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — enzymatic activity (HJ resolvase) co-fractionates with complex; co-IP confirmation; two orthogonal methods in single lab\",\n      \"pmids\": [\"17114795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"XRCC3 variant D213N is defective in homologous recombination and causes increased apoptosis of cells with mitotic defects (elevated centrosome number, binucleated cells), whereas T241M is proficient in HR but also increases centrosome number/binucleation without inducing apoptosis, suggesting T241M may promote cancer by failing to eliminate mitotically aberrant cells.\",\n      \"method\": \"HR assay (MMC sensitivity complementation); centrosome counting; binucleation assay; apoptosis measurement in cells expressing XRCC3 variants\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cellular phenotype readouts for two defined variants, single lab\",\n      \"pmids\": [\"16505003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"XRCC3 deletion in DT40 cells and γH2AX mutation are synthetically lethal; both independently delay Rad51 focus formation after IR through separate arms of a branched pathway for Rad51 assembly at DSBs.\",\n      \"method\": \"Chicken DT40 double-mutant generation (XRCC3−/−/H2AX−/S139A); clonogenic survival; Rad51 focus formation; chromosomal aberration analysis; conditional transgene rescue\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis via synthetic lethality in vertebrate cells, conditional rescue experiment, multiple phenotypic readouts\",\n      \"pmids\": [\"17123873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"XRCC3 activity generates recombination intermediates (substrates) that give rise to elevated sister chromatid exchanges (SCE) in BLM-deficient cells; BLM with Top3α acts downstream of XRCC3 to suppress SCE formation. Disruption of XRCC3 also suppresses MMS/UV sensitivity and chromosomal aberrations of blm cells.\",\n      \"method\": \"DT40 double/triple mutant genetics; SCE assay; clonogenic survival; chromosomal aberration analysis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis using clean double/triple mutants in DT40, multiple phenotypic readouts, places BLM downstream of XRCC3\",\n      \"pmids\": [\"17923529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"FANCG promotes formation of a protein complex containing BRCA2 (FANCD1), FANCD2, FANCG, and XRCC3 (D1-D2-G-X3); phosphorylation of FANCG serine 7 is required for co-precipitation of BRCA2, XRCC3, and FANCD2, and for direct BRCA2–FANCD2 interaction. FANCG and XRCC3 are epistatic for sensitivity to DNA crosslinking agents in DT40 cells.\",\n      \"method\": \"Co-immunoprecipitation from human and hamster cells; phospho-mutant FANCG constructs; DT40 epistasis analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP defining multi-protein complex, phospho-mutant functional analysis, genetic epistasis in DT40, multiple orthogonal methods\",\n      \"pmids\": [\"18212739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"XRCC3-mediated homologous recombination and suppression of long-tract gene conversion (LTGC) during sister chromatid recombination are dependent on ATP binding and hydrolysis by XRCC3, whereas the analogous XRCC2 function does not require ATP binding/hydrolysis.\",\n      \"method\": \"Sister chromatid recombination assay in hamster cells; XRCC3 Walker motif mutants; quantification of short-tract vs. long-tract gene conversion\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of ATPase motif with quantitative recombination assay, identifies distinct mechanistic requirement for XRCC3 vs. XRCC2\",\n      \"pmids\": [\"19470754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ATR kinase phosphorylates XRCC3 at serine 225 (SQ motif) in an ATM-dependent signaling context; this phosphorylation requires RAD51C but not XRCC2, occurs after end resection specifically in S and G2 phases, and is required for chromatin loading of RAD51 and HR-mediated DSB repair. XRCC3 phosphorylation is also required for intra-S-phase checkpoint activation and for HR-mediated recovery of collapsed (but not stalled) replication forks; XRCC3 participates in the G2/M checkpoint independently of its phosphorylation.\",\n      \"method\": \"Phospho-specific antibodies; kinase inhibitors; phospho-site mutagenesis (S225A); siRNA; HR assay; checkpoint and replication fork recovery assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — phospho-site mutagenesis combined with multiple orthogonal functional readouts (HR, checkpoint, fork recovery), identifies writer (ATR/ATM pathway) and reader context\",\n      \"pmids\": [\"23438602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"XRCC3 cysteine residues are oxidized by ROS (UVA, various oxidants) in mammalian cells, causing increased electrophoretic mobility; oxidation is rapidly reversed by cellular reducing systems. XRCC3 localizes to both cytoplasm and nucleus; mutating all cysteines to serines does not affect localization but confers sensitivity to camptothecin (HR defect), while oxidative stress induces chromatin relocalization of both wild-type and cysteine mutant XRCC3.\",\n      \"method\": \"Non-reducing SDS-PAGE; glutathione depletion; site-directed mutagenesis (Cys→Ser); subcellular fractionation; immunofluorescence; clonogenic survival\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis and fractionation with functional survival assay, single lab, multiple readouts\",\n      \"pmids\": [\"24116071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RAD51C/XRCC3 localizes to mitochondria and to the mitochondrial D-loop nucleoid region; this recruitment depends on Twinkle helicase. Absence of RAD51C/XRCC3 reduces POLG stability on mtDNA, decreases mtDNA synthesis, and increases mtDNA lesions under replication stress, establishing a nucleus-independent role in mitochondrial genome maintenance.\",\n      \"method\": \"Subcellular fractionation; chromatin immunoprecipitation on mtDNA; siRNA knockdown; mtDNA synthesis assay; mtDNA lesion quantification; co-immunoprecipitation with POLG and Twinkle\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (fractionation, ChIP on mtDNA, KD phenotype, co-IP), defines new subcellular role with functional consequence\",\n      \"pmids\": [\"29158291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"X-ray co-crystal structure of the RAD51C–XRCC3 (CX3) heterodimer with bound ATP analog reveals ATP-binding mode matching RAD51 recombinase, distinct CX3 interfaces, and an unappreciated polymerization motif. Cancer patient mutations mapped onto the structure define separable RAD51C functions: CX3 has discrete regions for DNA replication fork protection, restart, and reversal accomplished by separable DNA-binding and implied 5′ RAD51 filament capping activities.\",\n      \"method\": \"X-ray crystallography; CRISPR/Cas9 editing of human cells; single-molecule and single-cell assays; biophysics measurements; HDR functional analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus orthogonal functional validation (CRISPR edited cells, single-molecule assays, biophysics), multiple mechanistic readouts in one study\",\n      \"pmids\": [\"37488098\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"XRCC3 is a RAD51 paralog that forms a stable heterodimeric complex with RAD51C (structure now resolved by X-ray crystallography with bound ATP analog); the complex binds ssDNA, catalyzes homologous pairing, and is required for loading RAD51 onto resected DSB ends to execute homology-directed repair and suppress long-tract gene conversion. XRCC3's ATPase activity (Walker A motif K113) is essential for both HR repair and dynamic regulation of the RAD51C–XRCC3 complex. ATR/ATM-dependent phosphorylation of XRCC3 at Ser225 (requiring RAD51C) controls chromatin loading of RAD51, intra-S and G2/M checkpoints, and recovery of collapsed replication forks. XRCC3 localizes to DSBs independently of RAD51 and participates in a BRCA2–FANCD2–FANCG–XRCC3 complex (assembled via FANCG pSer7) for crosslink repair. Additionally, RAD51C/XRCC3 resides in the mitochondrial nucleoid at D-loop regulatory regions (Twinkle-dependent) where it maintains POLG stability and mtDNA integrity under replication stress.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"XRCC3 is a RAD51-family paralog that operates as a core component of homologous recombination, executing error-free homology-directed repair of DNA double-strand breaks and maintaining chromosomal stability [#0, #2, #4]. It forms a stable heterodimeric complex with RAD51C in which the two subunits are mutually stabilizing — XRCC3 elevates RAD51C levels and, reciprocally, XRCC3 protein stability depends on heterodimerization with RAD51C [#7, #12]. Within this complex XRCC3 is essential for single-stranded DNA binding while RAD51C provides the catalytic activity, and the reconstituted complex catalyzes homologous pairing and forms filamentous protein–DNA structures [#5, #6]. Functionally, XRCC3 acts upstream of RAD51 nucleoprotein filament assembly: it is required for the formation of damage-induced RAD51 subnuclear foci and localizes to DNA breaks independently of RAD51, consistent with priming RAD51 loading at resected ends [#1, #11]. XRCC3's ATPase activity (Walker A motif K113) is essential for recombinational repair and for suppression of long-tract gene conversion during sister chromatid recombination, with ATP binding/hydrolysis dynamically regulating RAD51C–XRCC3 complex formation [#10, #18]. The complex governs replication fork progression on damaged templates and co-fractionates with Holliday junction resolvase activity, generating recombination intermediates that are processed downstream by BLM–Top3α [#9, #13, #16]. ATR/ATM-dependent phosphorylation of XRCC3 at Ser225, which requires RAD51C, controls RAD51 chromatin loading, intra-S checkpoint activation, and recovery of collapsed replication forks [#19]. XRCC3 additionally participates in a BRCA2–FANCD2–FANCG–XRCC3 complex assembled via FANCG Ser7 phosphorylation for crosslink repair, and the RAD51C/XRCC3 complex carries a nucleus-independent role at the mitochondrial D-loop, where Twinkle-dependent recruitment maintains POLG stability and mtDNA integrity under replication stress [#17, #21]. A co-crystal structure of the RAD51C–XRCC3 heterodimer with bound ATP analog defines its ATP-binding mode and a polymerization motif, and maps separable replication fork protection, restart, and reversal functions [#22].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established XRCC3 as a RAD51-family member that physically engages RAD51 and rescues the DNA-damage sensitivity of a mutant cell line, placing it in the recombinational repair machinery.\",\n      \"evidence\": \"Sequence alignment, functional complementation of irs1SF hamster cells, and direct interaction assay with HsRad51\",\n      \"pmids\": [\"9660962\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define a biochemical activity for XRCC3 itself\", \"Stoichiometry and direct binding partners beyond RAD51 unresolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Showed XRCC3 acts upstream of RAD51 assembly by demonstrating it is required for damage-induced RAD51 focus formation.\",\n      \"evidence\": \"Immunofluorescence of RAD51 foci in irs1SF cells with and without XRCC3 complementation after IR or cisplatin\",\n      \"pmids\": [\"9705276\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of how XRCC3 promotes focus assembly not defined\", \"Direct versus indirect role unresolved at this stage\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Quantified XRCC3's contribution as essential for error-free homology-directed repair of double-strand breaks.\",\n      \"evidence\": \"Fluorescence-based HDR assay showing 25-fold reduction in XRCC3-deficient cells, restored by complementation\",\n      \"pmids\": [\"10541549\", \"10725659\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Step in HDR pathway requiring XRCC3 not pinpointed\", \"Did not address mitotic or checkpoint consequences\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Connected loss of XRCC3 to genome instability beyond repair failure, linking unresolved DNA damage to chromosome missegregation and centrosome fragmentation.\",\n      \"evidence\": \"Cytogenetic analysis of chromosome segregation and centrosome morphology in XRCC3-null cells\",\n      \"pmids\": [\"11025669\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal chain from repair defect to centrosome amplification not mechanistically dissected\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Reconstituted the RAD51C–XRCC3 heterodimer biochemically and assigned subunit roles — XRCC3 confers ssDNA binding, RAD51C is catalytic — and showed the complex catalyzes homologous pairing.\",\n      \"evidence\": \"Baculovirus co-expression, co-purification, co-IP from HeLa, EM, DNA-binding and in vitro homologous pairing assays\",\n      \"pmids\": [\"11459987\", \"11331762\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How homologous pairing activity relates to RAD51 loading in cells not resolved\", \"Regulation of complex activity unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined XRCC3's place within the paralog network as part of a discrete RAD51C–XRCC3 complex distinct from the RAD51B–RAD51C–RAD51D–XRCC2 complex, with mutual subunit stabilization.\",\n      \"evidence\": \"Reciprocal His-tag pull-downs and Western blotting in stable human cell lines\",\n      \"pmids\": [\"11842112\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional division of labor between the two paralog complexes not established\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Tested the cancer-associated Thr241Met polymorphism functionally and found it HDR-proficient, separating disease association from intrinsic repair disruption.\",\n      \"evidence\": \"Quantitative HDR assay and MMC sensitivity in complemented XRCC3-mutant cells\",\n      \"pmids\": [\"12037675\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Non-HDR routes by which the variant might contribute to cancer not addressed here\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated a replication-associated function: the RAD51C–XRCC3 complex modulates fork progression on damaged templates, with the defect rescued by purified complex and bypassed by RAD51.\",\n      \"evidence\": \"DNA fiber analysis and in vitro replication in permeabilized CHO and DT40 cells with purified complex addition\",\n      \"pmids\": [\"12718895\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular event at the fork requiring XRCC3 not defined\", \"Relationship to RAD51 loading at forks unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified XRCC3 ATPase activity (Walker A K113) as essential for repair and as a regulator of complex dynamics, with ATP binding modulating RAD51C–XRCC3 association.\",\n      \"evidence\": \"Walker A mutagenesis (K113A/K113R), mammalian complementation, bacterial co-expression and purification\",\n      \"pmids\": [\"15037616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ATP-driven dynamics couple to RAD51 loading in vivo not shown\", \"Catalytic versus structural role of hydrolysis not fully separated\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed XRCC3 localizes to breaks within minutes independently of RAD51, supporting a model where it associates with DNA breaks before facilitating RAD51 filament assembly; and confirmed XRCC3 stability depends on RAD51C.\",\n      \"evidence\": \"Immunofluorescence of XRCC3 foci with RAD51 RNAi; siRNA depletion of RAD51C with Western, HR, and survival readouts\",\n      \"pmids\": [\"15372620\", \"15292210\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"RAD51-independent recruitment shown by single method (idx 11)\", \"Recruitment receptor at breaks not identified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Linked the complex to resolution of recombination intermediates by showing co-elution with Holliday junction resolvase activity.\",\n      \"evidence\": \"IP, gel filtration, HJ resolvase assay, and meiotic chromosome immunofluorescence\",\n      \"pmids\": [\"17114795\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether XRCC3/RAD51C is the resolvase or an associated factor not resolved\", \"Identity of catalytic resolvase activity not assigned\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Dissected two XRCC3 variants to show HR proficiency and mitotic surveillance are separable, with T241M increasing centrosome/binucleation defects without triggering apoptosis.\",\n      \"evidence\": \"HR complementation, centrosome counting, binucleation and apoptosis assays for D213N and T241M variants\",\n      \"pmids\": [\"16505003\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab variant phenotyping\", \"Mechanism linking XRCC3 to apoptotic elimination of aberrant cells not defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Positioned XRCC3 in a branched RAD51-loading pathway by showing synthetic lethality with γH2AX, with each acting through a separate arm.\",\n      \"evidence\": \"DT40 double mutants (XRCC3−/−/H2AX−), clonogenic survival, RAD51 focus and aberration analysis with conditional rescue\",\n      \"pmids\": [\"17123873\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular distinction between the two RAD51-loading arms not fully defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Placed XRCC3 upstream of BLM–Top3α by showing XRCC3 generates recombination intermediates that BLM resolves to suppress sister chromatid exchange.\",\n      \"evidence\": \"DT40 double/triple mutant epistasis, SCE assay, survival and chromosomal aberration analysis\",\n      \"pmids\": [\"17923529\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nature of the XRCC3-generated intermediate not biochemically defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Embedded XRCC3 in the Fanconi crosslink-repair axis via a phospho-dependent BRCA2–FANCD2–FANCG–XRCC3 complex.\",\n      \"evidence\": \"Co-IP from human and hamster cells, FANCG pSer7 phospho-mutant constructs, DT40 epistasis with crosslinkers\",\n      \"pmids\": [\"18212739\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct XRCC3 contact within the complex not mapped\", \"How this complex couples to HR machinery not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified XRCC3 Ser225 as an ATR/ATM-pathway phosphosite (RAD51C-dependent) controlling RAD51 chromatin loading, the intra-S checkpoint, and collapsed-fork recovery, separating these from a phosphorylation-independent G2/M checkpoint role.\",\n      \"evidence\": \"Phospho-specific antibodies, kinase inhibitors, S225A mutagenesis, siRNA, HR, checkpoint and fork recovery assays\",\n      \"pmids\": [\"23438602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct reader of phospho-Ser225 not identified\", \"Structural consequence of phosphorylation not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Revealed redox regulation: XRCC3 cysteines are reversibly oxidized by ROS and required for HR/camptothecin resistance, with oxidative stress driving chromatin relocalization.\",\n      \"evidence\": \"Non-reducing SDS-PAGE, glutathione depletion, Cys→Ser mutagenesis, fractionation, immunofluorescence, clonogenic survival\",\n      \"pmids\": [\"24116071\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"Physiological context where cysteine oxidation regulates XRCC3 not established\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Uncovered a nucleus-independent mitochondrial role: Twinkle-dependent recruitment of RAD51C/XRCC3 to the mtDNA D-loop maintains POLG stability and mtDNA integrity under replication stress.\",\n      \"evidence\": \"Subcellular fractionation, ChIP on mtDNA, siRNA, mtDNA synthesis and lesion assays, co-IP with POLG and Twinkle\",\n      \"pmids\": [\"29158291\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mitochondrial function uses HR-like activity not resolved\", \"Direct XRCC3 contribution versus RAD51C not separated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Provided the structural basis for XRCC3 function — a RAD51C–XRCC3 co-crystal with bound ATP analog revealing the ATP-binding mode, complex interfaces, and a polymerization motif, with mapping of separable fork protection/restart/reversal functions.\",\n      \"evidence\": \"X-ray crystallography, CRISPR editing, single-molecule and single-cell assays, biophysics, HDR analysis\",\n      \"pmids\": [\"37488098\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the complex engaged with DNA or RAD51 filament not resolved\", \"Implied 5′ filament capping activity not directly visualized\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How XRCC3's distinct activities — nuclear HR, replication fork protection, crosslink repair, and mitochondrial genome maintenance — are coordinated, and what directly reads its regulatory modifications, remains open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No reader of phospho-Ser225 identified\", \"Structural picture of DNA/RAD51-engaged complex lacking\", \"Coupling of mitochondrial and nuclear roles undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [10, 18, 22]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5, 6]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [10, 18]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 1, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 11, 20]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [11, 19]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [0, 2, 3, 19]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [9, 19, 21]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [4, 13, 19]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [21]}\n    ],\n    \"complexes\": [\n      \"RAD51C–XRCC3 (CX3) heterodimer\",\n      \"BRCA2–FANCD2–FANCG–XRCC3\",\n      \"mitochondrial D-loop nucleoid complex (with POLG/Twinkle)\"\n    ],\n    \"partners\": [\n      \"RAD51C\",\n      \"RAD51\",\n      \"BRCA2\",\n      \"FANCD2\",\n      \"FANCG\",\n      \"POLG\",\n      \"TWNK\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}